A detailed history of Jpmorgan Chase & CO transactions in Quidel Ortho Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,233,480 shares of QDEL stock, worth $46.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,233,480
Previous 1,287,986 4.23%
Holding current value
$46.2 Million
Previous $42.8 Million 31.43%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$29.96 - $46.4 $1.63 Million - $2.53 Million
-54,506 Reduced 4.23%
1,233,480 $56.2 Million
Q2 2024

Aug 12, 2024

SELL
$32.9 - $47.0 $2.6 Million - $3.72 Million
-79,166 Reduced 5.79%
1,287,986 $42.8 Million
Q1 2024

May 10, 2024

BUY
$41.76 - $74.73 $1.34 Million - $2.4 Million
32,140 Added 2.41%
1,367,152 $65.5 Million
Q4 2023

Feb 12, 2024

BUY
$58.16 - $75.44 $3.67 Million - $4.76 Million
63,077 Added 4.96%
1,335,012 $98.4 Million
Q3 2023

Nov 14, 2023

BUY
$70.9 - $88.63 $5.69 Million - $7.11 Million
80,218 Added 6.73%
1,271,935 $92.9 Million
Q2 2023

Aug 11, 2023

SELL
$81.09 - $94.16 $679,372 - $788,872
-8,378 Reduced 0.7%
1,191,717 $98.7 Million
Q1 2023

May 18, 2023

BUY
$82.98 - $91.46 $7.63 Million - $8.41 Million
91,953 Added 8.3%
1,200,095 $107 Million
Q1 2023

May 11, 2023

BUY
$82.98 - $91.46 $552,065 - $608,483
6,653 Added 0.6%
1,108,142 $98.7 Million
Q4 2022

Feb 13, 2023

BUY
$66.93 - $97.5 $1.42 Million - $2.06 Million
21,145 Added 1.96%
1,101,489 $94.4 Million
Q3 2022

Nov 14, 2022

BUY
$69.86 - $107.63 $14.8 Million - $22.8 Million
212,143 Added 24.43%
1,080,344 $77.2 Million
Q2 2022

Aug 11, 2022

BUY
$89.06 - $117.64 $77.3 Million - $102 Million
868,201 New
868,201 $84.4 Million

Others Institutions Holding QDEL

About QuidelOrtho Corp


  • Ticker QDEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 66,952,900
  • Market Cap $2.51B
  • Description
  • QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...
More about QDEL
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.